Results for tag: "Encorafenib"

Encorafenib is a type of skin cancer drug used to treat melanoma, a type of skin cancer. It is a kinase inhibitor, meaning it works by blocking certain proteins that help cancer cells grow and divide. Encorafenib is typically used in combination with binimetinib, another kinase inhibitor, to treat advanced melanoma. It is approved by the US Food and Drug Administration (FDA) for use in adults with BRAF V600E or V600K mutation-positive melanoma. Encorafenib is a relatively new drug, having been approved by the FDA in 2018. It is used to treat advanced melanoma, which is a particularly aggressive form of skin cancer. It is typically used in combination with binimetinib, and is often used in combination with other treatments such as chemotherapy and radiation therapy. Encorafenib is marketed by several companies, including Novartis, Pfizer, and Merck. It is also available in generic form from several generic drug manufacturers. Encorafenib is a promising treatment for advanced melanoma, and is becoming increasingly popular as a treatment option. Companies such as Novartis, Pfizer, and Merck are leading the way in the development and marketing of this drug. Show Less Read more